BioSpace News Archive

Bioengineered Proteins Drugs Market: Vaccines Slated to Grow at Maximum Pace due to Development of Bioengineered Prophylactic Vaccines

Bioengineering is the application of engineering technology and methods to the field of biology. Polymer of amino acids, proteins play a significant role in facilitating smooth functioning of the human body.

March 1, 2021
·
6 min read
Erythropoietin Drugs Market: Introduction of Biosimilars to Emerge as Key Market Trend

The global erythropoietin drugs market is prognosticated to demonstrate steady growth in coming years, as reported by Transparency Market Research.

March 1, 2021
·
4 min read
Plasma Protease C1-inhibitor Treatment Market: Rise in Research Efforts Aimed at Development of Novel C1-inhibitor Drug Classes to Bode Well for Market

The global plasma protease C1-inhibitor treatment market is foreseen to display robust growth in the future due to the increasing cases of acute hereditary angioedema and prophylaxis.

March 1, 2021
·
5 min read
Porcine Vaccines Market Witness High Investment Inflow for Research and Development of Vaccines

The global porcine vaccines market is expanding due to growing prevalence of swine diseases across the globe.

March 1, 2021
·
6 min read
Rare Hematology Market: Increasing number of Clinical Trials to Encourage Progress

Growing prevalence of various blood diseases such as anemia, myeloma, leukemia and sickle cell anemia has led the hematologists to focus on various detection processes.

March 1, 2021
·
5 min read
Autologous Matrix-induced Chondrogenesis Market: Rising Demand for Minimally Invasive Surgeries to Encourage Market Growth

Autologous matrix-induced chondrogenesis applies bi-layer collagen membrane through microfracture surgery to fix the damage to the articular cartilage damage.

March 1, 2021
·
4 min read
Rheumatology Therapeutics Market: Rising Prevalence of Rheumatology Diseases to Boost Growth

A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.

March 1, 2021
·
4 min read
Drug Development

Ocular Therapeutix™ Announces First Patient Dosed in Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

Ocular Therapeutix ™ Announces First Patient Dosed in Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

March 1, 2021
·
8 min read
Deals

Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million

-- Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography –

March 1, 2021
·
7 min read
Business

Digital Health Leader Mark Hirschhorn Joins Hygieia Board as Company Ramps Up for Growth of Its Unique d-Nav® Insulin Management Technology

Hygieia, a digital health company, is accelerating its operations as demand increases for d-Nav®, the only FDA-cleared technology that automates dose adjustments for patients who inject insulin.

March 1, 2021
·
3 min read